Skip to main content

Now available

Navicor

by Augury Medical

Expert cardiology
for primary care.

Navicor matches the clinical findings you already have to current ACC/AHA cardiology guidelines, making actionable guidance quick and easy to find.

Available to clinicians in the United States.

Navicor clinical decision support interface showing cardiology guideline recommendations

Why Navicor

Refer now, or manage here?

It's one of the hardest calls in primary care. Navicor shows you what the ACC/AHA guidelines recommend for your patient's findings, and why.

GP in attentive, confident consultation — supported by guideline-based decision support

Transparent by design

Every match shows the guideline recommendation it's based on, the reasoning behind it, and the source, so you can review it and make the call yourself.

Built for the time you have

Input the findings you already have and see the relevant recommendations in moments. No manual guideline search, and no specialist vocabulary needed to ask the right question.

Clear next steps

See which diagnostics the guidelines suggest, and when a referral to cardiology is recommended. Actionable guidance, not more reference material.

No patient records, no setup

Navicor works from clinical findings, not patient records. No PHI, no EHR integration, no installation.

How it works

From clinical findings to guideline recommendations in three steps.

Input clinical findings

Enter what you already know: symptoms, relevant history, and findings from your own ECG read, such as QRS duration or bundle branch block. No patient identifiers.

Matched to ACC/AHA guidelines

Navicor compares your inputs against ACC/AHA guideline criteria and identifies the recommendations that apply.

Review the reasoning, decide the next step

See each matching recommendation with its reasoning and guideline source. If information is missing, Navicor shows which findings would help clarify the picture. The clinical decision stays with you.

See it in practice

One patient, start to finish.

Your findings

  • NYHA class II
  • ECG: sinus rhythm, left bundle branch block, QRS 160 ms
  • Echo: LVEF 30%
  • On guideline-directed medical therapy

What Navicor shows

Matched recommendation
Referral to cardiology for evaluation for cardiac resynchronization therapy (CRT)
Why
LVEF ≤35%, sinus rhythm, LBBB with QRS ≥150 ms, and symptoms despite guideline-directed medical therapy
Source
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure

Illustrative example. Not a real patient. Navicor supports, and does not replace, the clinical judgment of qualified healthcare professionals.

Pricing

One simple plan.

Full access to every Navicor feature for one monthly price. Start with a free 30-day trial, and cancel anytime.

Subscribing for a team or practice? Contact us.

Navicor

$19.95/ month per user

  • All Navicor features
  • Billed monthly
  • Cancel anytime
  • Free 30-day trial available

Prices in US dollars. Applicable taxes are added at checkout. Available to clinicians in the United States.

Built for clinicians

Grounded in guidelines. Built with physicians.

ACC/AHA guideline-based

Recommendations are drawn from current ACC/AHA cardiology guidelines and reviewed as guidelines are updated.

Developed with clinicians

Shaped through interviews and testing with primary care physicians and cardiologists in Switzerland and the US.

Rooted in research

Augury Medical is a spin-off of the Bern University of Applied Sciences (BFH), building on applied cardiac research.

Navicor is clinical decision support for qualified healthcare professionals. It supports, and does not replace, clinical judgment.

Now available in the US

Bring expert cardiology to your practice today.

Input clinical findings in seconds. No patient records, no EHR setup, no specialist knowledge required. Try it free for 30 days1,2, then $19.95/month. Cancel anytime.

Supported & recognised by

Ypsomed Innovationsfonds
Innosuisse BRIDGE
Innosuisse
Venture Kick
Gebert Rüf Stiftung
Kickfund
Gütezeichen Challenge
VentureLab
Ypsomed Innovationsfonds
Innosuisse BRIDGE
Innosuisse
Venture Kick
Gebert Rüf Stiftung
Kickfund
Gütezeichen Challenge
VentureLab
Ypsomed Innovationsfonds
Innosuisse BRIDGE
Innosuisse
Venture Kick
Gebert Rüf Stiftung
Kickfund
Gütezeichen Challenge
VentureLab
Ypsomed Innovationsfonds
Innosuisse BRIDGE
Innosuisse
Venture Kick
Gebert Rüf Stiftung
Kickfund
Gütezeichen Challenge
VentureLab